139 related articles for article (PubMed ID: 21553322)
1. Elevated plasma advanced oxidation protein products in children with Henoch-Schonlein purpura.
Keskin N; Civilibal M; Elevli M; Koldas M; Duru NS; Ozturk H
Pediatr Nephrol; 2011 Nov; 26(11):1989-93. PubMed ID: 21553322
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil activation, protein oxidation and ceruloplasmin levels in children with Henoch-Schönlein purpura.
Ece A; Kelekçi S; Hekimoğlu A; Kocamaz H; Balik H; Yolbaş I; Erel O
Pediatr Nephrol; 2007 Aug; 22(8):1151-7. PubMed ID: 17404760
[TBL] [Abstract][Full Text] [Related]
3. [Clinical Significance of Serum Midkine in Children with Henoch-Schonlein Purpura].
Li MM; Liu N; Zhagn M; Xue HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):181-185. PubMed ID: 28245398
[TBL] [Abstract][Full Text] [Related]
4. Serum level of advanced oxidation protein products (AOPPs) in patients with Henoch-Schonlein purpura and its relationship with aberrant glycosylation of IgA1 and Cosmc mRNA expression.
Liu Q; Yang Y; Ge S; Huo J; Wang D; Ma Y; Shi S; Luo D; Deng J; Ren C; Guo B
Int J Dermatol; 2019 Sep; 58(9):1092-1097. PubMed ID: 31250447
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schönlein purpura.
Ece A; Kelekçi S; Kocamaz H; Hekimoğlu A; Balik H; Yolbaş I; Erel O
Clin Rheumatol; 2008 Feb; 27(2):163-9. PubMed ID: 17646900
[TBL] [Abstract][Full Text] [Related]
6. Do practical laboratory indices predict the outcomes of children with Henoch-Schönlein purpura?
Ekinci RMK; Balci S; Sari Gokay S; Yilmaz HL; Dogruel D; Altintas DU; Yilmaz M
Postgrad Med; 2019 May; 131(4):295-298. PubMed ID: 31021301
[No Abstract] [Full Text] [Related]
7. [Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis].
Ru L; Abudouhaer A; Guo YF
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):1009-13. PubMed ID: 24229600
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-lymphocyte ratio to predict gastrointestinal bleeding in Henoch: Schönlein purpura.
Hong SH; Kim CJ; Yang EM
Pediatr Int; 2018 Sep; 60(9):791-795. PubMed ID: 29947449
[TBL] [Abstract][Full Text] [Related]
9. Platelet Counts in Children With Henoch-Schonlein Purpura--Relationship to Renal Involvement.
Elmas AT; Tabel Y
J Clin Lab Anal; 2016 Jan; 30(1):71-4. PubMed ID: 25385472
[TBL] [Abstract][Full Text] [Related]
10. Endothelin levels in Henoch-Schonlein purpura.
Muslu A; Islek I; Gok F; Aliyazicioglu Y; Dagdemir A; Dundaroz R; Kucukoduk S; Sakarcan A
Pediatr Nephrol; 2002 Nov; 17(11):920-5. PubMed ID: 12432435
[TBL] [Abstract][Full Text] [Related]
11. An analysis of the levels of the soluble form of the endothelial protein C receptor in children with Henoch-Schönlein Purpura.
Cayci FS; Ekim M; Egin Y; Gökce H; Yalcinkaya F; Ozcakar B; Akar N
Pediatr Hematol Oncol; 2015 Mar; 32(2):115-22. PubMed ID: 24308805
[TBL] [Abstract][Full Text] [Related]
12. Is Henoch-Schönlein purpura a susceptibility factor for functional gastrointestinal disorders in children?
Kisla Ekinci RM; Balcı S; Mart OO; Tumgor G; Yavuz S; Celik H; Dogruel D; Altintas DU; Yilmaz M
Rheumatol Int; 2019 Feb; 39(2):317-322. PubMed ID: 30101368
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide in Henoch-Schönlein purpura.
Söylemezoğlu O; Ozkaya O; Erbaş D; Akkök N; Buyan N; Hasanoğlu E
Scand J Rheumatol; 2002; 31(5):271-4. PubMed ID: 12455816
[TBL] [Abstract][Full Text] [Related]
15. Predictive role of laboratory markers and clinical features for recurrent Henoch-Schönlein Purpura in childhood: A study from Turkey.
Gökçe Ş; Kurugöl Z; Koturoğlu G; Aslan A
Mod Rheumatol; 2020 Nov; 30(6):1047-1052. PubMed ID: 31711347
[No Abstract] [Full Text] [Related]
16. Differences between adult and pediatric onset Henoch-Schonlein purpura from North India.
Gupta V; Aggarwal A; Gupta R; Chandra Chowdhury A; Agarwal V; Lawrence A; Misra R
Int J Rheum Dis; 2018 Jan; 21(1):292-298. PubMed ID: 29115055
[TBL] [Abstract][Full Text] [Related]
17. MEFV gene variants in children with Henoch-Schönlein purpura and association with clinical manifestations: a single-center Mediterranean experience.
Ekinci RMK; Balci S; Bisgin A; Atmis B; Dogruel D; Altintas DU; Yilmaz M
Postgrad Med; 2019 Jan; 131(1):68-72. PubMed ID: 30513227
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of the serum biomarker index detection in children with Henoch-Schonlein purpura.
Purevdorj N; Mu Y; Gu Y; Zheng F; Wang R; Yu J; Sun X
Clin Biochem; 2018 Feb; 52():167-170. PubMed ID: 29129626
[TBL] [Abstract][Full Text] [Related]
19. Mean platelet volume in Henoch-Schönlein purpura: relationship to gastrointestinal bleeding.
Makay B; Türkyilmaz Z; Duman M; Unsal E
Clin Rheumatol; 2009 Oct; 28(10):1225-8. PubMed ID: 19543767
[TBL] [Abstract][Full Text] [Related]
20. Altered mean platelet volume in children with Henoch-Schonlein purpura and its association with disease activity.
Shi X; Li WC; Mo LJ; Li XH; Luo YZ; Qin LQ; Yang Z; Mo WN
Ann Clin Biochem; 2018 May; 55(3):368-372. PubMed ID: 28774183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
